Core Insights - The article highlights the performance and strategies of Zhixin Rongke, a quantitative private equity firm, which has shown impressive returns in the market, particularly in the CTA (Commodity Trading Advisor) category [4][13][24]. Company Overview - Zhixin Rongke Investment Management (Beijing) Co., Ltd. was established in 2013 by PhDs from Tsinghua University and the Chinese University of Hong Kong, focusing on quantitative investment with over 10 years of experience in CTA strategies and 5 years in quantitative stock strategies [13][14]. - The firm has developed a dual-driven strategy system centered on quantitative CTA and quantitative stock selection, aiming for high Sharpe ratios and low drawdowns [13][24]. Performance Metrics - As of October 2025, Zhixin Rongke's products have achieved significant average returns, ranking second among quantitative private equity firms and sixth among those with assets over 5 billion [4][10]. - The "Zhixin Rongke CTA No. 7 A Class" product ranked third in terms of returns and drawdown control among CTA products, showcasing its strong performance [4][8]. Investment Strategies - The firm employs a dual-engine strategy that combines CTA and quantitative stock selection, providing both trend-following returns and tail risk hedging [41][45]. - The strategies have demonstrated crisis alpha, achieving positive returns during market downturns, such as a +***% return when the CSI 300 index fell by 21.6% in 2022 [41][42]. Team and Development - The core team has over 15 years of stable collaboration, previously working at the renowned hedge fund WorldQuant, which enhances their research and investment capabilities [17][21]. - The firm has undergone several strategy iterations since its inception, continuously adapting to market changes and improving performance metrics [46]. Product Lines - Zhixin Rongke offers various product lines, including CTA-enhanced strategies and quantitative stock selection strategies, catering to different investor risk preferences [24][30]. - The "CTA No. 7" product is positioned as a flagship quantitative CTA product, while the "Multi-Strategy No. 8" integrates both CTA and quantitative stock selection for enhanced absolute returns [28][30].

Core Insights - The private equity industry has returned to the "double hundred era," with 113 billion-yuan private equity firms as of the end of November, including 55 quantitative private equity firms, indicating a significant increase in the popularity of quantitative investment [2][3] - The performance of quantitative private equity has gained recognition from most investors, with a total of 852 existing quantitative private equity firms [2] Group 1: Billion-Yuan Private Equity Landscape - As of November 2025, there are 55 billion-yuan quantitative private equity firms, with 14 firms breaking the 100 billion mark this year, a new high since 2022 [3][4] - The average time taken for these firms to reach the billion-yuan scale is approximately 7 years, with the fastest being Yanfu Investment at only 1.2 years [3][4] - The majority of billion-yuan quantitative private equity firms focus on stock strategies, with 47 firms, followed by multi-asset strategies with 6 firms [4] Group 2: Performance Rankings - The top three performing billion-yuan quantitative private equity firms this year are Lingjun Investment, Ningbo Huansheng Quantitative, and Wenbo Investment, with the threshold for the top 10 performance being ***% [7][11] - Lingjun Investment has consistently ranked high for three consecutive months, with an average return of ***% across its products [9][11] - The performance of quantitative private equity firms has been bolstered by the increasing trend of firms obtaining Hong Kong's Type 9 license for global investment and risk diversification, with 22 billion-yuan quantitative private equity firms currently holding this license [4] Group 3: Mid-Sized Private Equity Firms - In the 50-100 billion category, the top three firms are Yunqi Quantitative, Qianshu Investment, and Hainan Shengfeng Private Equity, with the performance threshold for the top 10 being over ***% [11][12] - Yunqi Quantitative, established in February 2021, has rapidly grown from a management scale of 10-20 billion to 50-100 billion this year [12] Group 4: Smaller Private Equity Firms - In the 20-50 billion category, the top three firms are Hanrong Investment, Xiangmu Asset, and Yinhhe Investment, with the performance threshold for the top 10 being over ***% [15] - The 10-20 billion category has seen a decrease in stock strategy firms, with multi-asset and futures strategies becoming more prominent [20][21] - In the 5-10 billion category, the top three firms are Huacheng Private Equity, Shanghai Zijie Private Equity, and Zhenzhen Investment, with performance thresholds exceeding ***% [22][25] Group 5: Emerging Firms - In the 0-5 billion category, the top three firms are Jingying Zhito, Jinwang Investment, and Quancheng Fund, with Jingying Zhito achieving significant returns [26][29] - Jingying Zhito, established in 2021, focuses on futures and derivatives strategies and is led by a team with extensive quantitative investment experience [29]

Core Insights - Deepseek has emerged as a significant player in the global AI landscape, revitalizing the quantitative investment sector, particularly in a market environment favoring small and mid-cap stocks [2] - In November, despite an overall adjustment in the A-share market, many quantitative products from billion-yuan private equity firms achieved historical highs, with quantitative products accounting for over 80% of these successes [2] - The average return for 1,833 quantitative products this year is 26.98%, with an excess (geometric) return of 11.41% [2][3] Quantitative Investment Performance - The average return for quantitative long strategies is 40.34%, with an excess return of 17.25%, making it the top performer among secondary strategies [3] - The performance of various quantitative strategies is summarized as follows: - Quantitative CTA: 16.32% average return, 13.76% excess return - Stock market neutral: 9.37% average return, -4.93% excess return - Composite strategies: 23.85% average return, 7.61% excess return - Options strategies: 11.04% average return, 8.60% excess return - Convertible bond trading strategies: 20.42% average return, 3.65% excess return - Arbitrage strategies: 11.63% average return, -2.96% excess return - Macro strategies: 21.72% average return, 5.69% excess return - Stock long-short: 15.05% average return, 0.01% excess return - FOF: 13.50% average return, -1.33% excess return - Bond composite strategies: 13.88% average return, 13.15% excess return - Pure bond strategies: 6.47% average return, 5.79% excess return - Other derivative strategies: 37.74% average return, 34.72% excess return - Bond enhancement: 11.47% average return, 10.76% excess return [3] Top Performing Quantitative Products - The "quantitative stock selection" products have an average return of 39.40% and an average excess return of 19.14% [4] - The top three products in the "quantitative stock selection" category are from: - Zhuhai Zhengfeng Private Equity - Shui Du Quan Asset - Jiu Ming Investment [5] - The "CSI 500 index enhancement" products have an average return of 40.17% and an average excess return of 14.14% [8] - The top three products in the "CSI 500 index enhancement" category are from: - Zhaoxin Private Equity Fund - Guobiao Asset - Zhaoyue Private Equity [9] - The "CSI 1000 index enhancement" products have an average return of 44.68% and an average excess return of 17.53% [13] - The top three products in the "CSI 1000 index enhancement" category are from: - Jintong Investment - Luxiu Investment - Mengxi Investment [13] Other Notable Strategies - The "CSI 300 index enhancement" products have an average return of 24.47% and an average excess return of 8.20% [17] - The top three products in the "CSI 300 index enhancement" category are from: - Hainan Pengpai Private Equity - Ningbo Huansheng Quantitative - Mingyun Investment [17] - The "other index enhancement" products have an average return of 42.58% and an average excess return of 20.13% [20] - The top three products in the "other index enhancement" category are from: - Yangshi Asset - Luxiu Investment - Shengguanda [21]

今年1-11月，在政策支持、产业突破等利好因素的背景下，A股结构性行情突出。其中，部分"小而美"私募凭借着灵活性和适应性，在中小盘股 整体表现占优的"慢牛"行情下，展现出较强的进攻性和爆发力。 私募排排网数据显示，规模为0-5亿的私募共有6195家，占所有私募总数的81.86%。其中，今年来至少有3只产品符合排名规则的私募共有238 家，平均收益为29.2%。 那么，究竟有哪些规模为0-5亿私募在今年的行情中表现更优呢？接下来，笔者将根据投资模式进行划分，盘点今年来收益位列10强的"小而 美"量化私募、主观私募和混合型私募。 本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 0 1 量化"小而美"：京盈智投、锦望投资、广州天钲瀚位列10强 在量化私募中，至少有3只产品符合排名规则的私募共有47家，今年来平均收益为 *** %，其中10强私募的上榜门槛为 *** %。（ 点此查看收益 ） [应监管要求，私募产品不能公开展示业绩，文中涉及收益数据用***替代，合格投资者可扫码查看收益数据。] 在10强量化私募中，核心策略为股票策略的私募有5家，占据半壁江山；另外还有3家私募为期货及衍生品策略，2家私 ...

Core Insights - The A-share market experienced its first adjustment in November after seven months of slow bullish trends, with an average return of -0.77% for 668 products from billion-yuan private equity firms, and only 40.42% of these products achieving positive returns [2][7] Group 1: Billion-yuan Private Equity Overview - As of the end of November, there are 113 billion-yuan private equity firms, maintaining the same number as the end of October, nearing the historical peak of 116 firms in March 2022 [2][3] - Two new firms, Yuankang Private Equity and Liwei Private Equity, have crossed the 100 billion yuan threshold in November, both focusing on bond strategies [2] Group 2: Investment Strategies and Performance - Among the 113 billion-yuan private equity firms, 55 are quantitative, 47 are subjective, and 9 employ a combination of both strategies [3] - In terms of core strategies, 85 firms focus on stock strategies, 12 on multi-asset strategies, 9 on bond strategies, and 2 on futures and derivatives [3] Group 3: Geographic Distribution and Employee Count - Shanghai has the highest number of private equity firms at 53, followed by Beijing with 29, and Shenzhen with 9 [4] - There are 14 firms with over 100 employees, including prominent names like Foreign Trade Trust and Jiukun Investment [4] Group 4: Internationalization Trends - 39 of the billion-yuan private equity firms have obtained the Hong Kong 9 license, an increase of 4 firms since October, indicating a trend towards internationalization [4] Group 5: Performance Metrics - The average return for billion-yuan private equity products from January to November is 29.44%, with quantitative products yielding an average return of 34.42%, outperforming non-quantitative products by over 10% [7] - The top three performing private equity firms from January to November are Lingjun Investment, Yuanxin Investment, and Fusheng Asset, with closely matched returns [7][12] Group 6: Long-term Performance - Over the past three years, the average return for billion-yuan private equity products is 69.72%, with the top firms being Jiuqi Investment, Dongfang Port Bay, and Qianyan Private Equity [12][19] - In the last five years, the average return is 87.07%, with Fusheng Asset leading the performance rankings [19]

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 临近 2025年末，以摩根大通、摩根士丹利、瑞银为代表的多家国际头部机构，正密集发布其2026年全球投资展望。多家外资机构在展望中明确 表达了对明年中国经济与资本市场前景的信心，认为中国股市的中长期配置价值正日益凸显。 为帮助投资者把握外资视角下的核心观点与动态，本文梳理了近期几家知名外资的主要研判，并汇总了自10月以来其对A股上市公司的评级调整 情况，以供参考。（ 点此领取名单 ） 0 1 摩根大通：明年沪深 300 剑指 5200 点！关注四大投资主题！首次覆盖北方华创、石化油服！ 在2026年投资展望中， 摩根大通策略团队将 A股评级上调至"超配" ，其认为相比潜在下行风险，中国股市明年迎来大幅上涨的概率更高，并指 出明年将迎来多项增量支撑因素，包括人工智能技术向更广泛领域的渗透、国内消费刺激政策的持续发力， 预计 2026年MSCI中国指数目标价 为100点，沪深300指数可涨至5200点（乐观场景看至6000点） 。其中，有四大投资方向值得关注： 第一， "反内卷"政策的加速推进 。当前MSCI中国指数的净利润率和ROE在亚太市场中处于 ...

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 12月8日，A股的AI算力概念股大涨。 当日市场成交额超100亿元的个股有11只，其中AI算力概念股占7只，成交额前6均是AI算力概念股，呈现 霸榜之势，光模块三杰"易中天"再次占据成交额前3强，足见资金的追捧程度。中际旭创、天孚通信均创下历史新高。东田微、汇绿生态、宏和 科技、景旺电子、光库科技等多只AI算力概念股涨停或大涨。 展望2026年，AI算力板块依然是很多机构看好的方向。 经过最近2-3个月的震荡盘整之后，资金再次聚集AI算力板块，或是部分机构在布局 2026年的行情。 AI算力板块走强背后主要是机构资金在推动 。为了给读者提供一些参考，笔者梳理出了公募基金、北向资金重仓以及机构最近调研过的AI算力 概念股。 （ 点此查看名单 ） 01 公募基金重仓中际旭创、新易盛均达千亿元！ 公募基金是 A股的主要机构投资者之一，也是史上多个赛道板块的主力资金之一 。根据Choice数据 统计，2025年三季度末， 有 38只AI算力概 念股被基金持股均超10亿元 ，其中，光模块公司中际旭创、新易盛均被基金持股超1100亿元，寒武纪、天孚通信等11 ...

Core Viewpoint - The article emphasizes the importance of considering both risk and return in investment, particularly in a volatile and uncertain market environment [2]. Group 1: Sharpe Ratio and Its Importance - The Sharpe Ratio is defined as the ratio of the excess return of an investment portfolio over the risk-free rate to the standard deviation of the portfolio's returns, serving as a measure of risk-adjusted return [3]. - The increasing focus on the Sharpe Ratio among investors highlights its role as a "cost-performance" indicator for risk and return [4]. - Data from "Private Equity排排网" shows that the average Sharpe Ratios for private equity products over the past year, three years, and five years are 1.69, 0.9, and 0.65, respectively, with products over 1 billion yuan showing higher averages [4]. Group 2: Top Performing Private Equity Products - In the past year, nine out of ten top-performing private equity products based on the Sharpe Ratio are quantitative long products, with "稳博小盘激进择时指增1号" leading the list [6][9]. - "幻方量化500指数专享65号1期" ranks third among the top products, utilizing AI for investment and achieving significant returns [9]. - For the past three years, "平方和财赢平衡1号B类份额" ranks first with a Sharpe Ratio exceeding *** [10][12]. Group 3: Trends in Investment Strategies - The article notes a trend towards quantitative strategies, with firms like 宁波幻方量化 and 君之健投资 leading in performance [9][10]. - The use of AI and advanced models in investment strategies is highlighted as a key factor for success, particularly in the context of deep learning and risk management [12]. - The article also mentions the increasing number of private equity firms obtaining licenses, indicating a growing market for private equity investments [16].

私募排排网最新数据显示，截至2025年11月21日，蒙玺投资旗下今年以来有业绩展示且符合排名规则的产品共有10只，均由李骧管理，今年 来平均收益为***%。其中，有8只为量化多头产品，它们今年来的平均超额收益为***%。（ 点击查看收益 ） [应监管要求，私募产品不能公开展示业绩，文中涉及收益数据用***替代，合格投资者可扫码查看收益数据。] 本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 今年以来，在市场流动性改善以及友好的策略环境下，多家量化私募凭借着其投研、风控、策略优势，进入百亿私募阵营。蒙玺投资就是其中一 家新晋的百亿量化私募。 蒙玺投资成立于2016年，是国内量化行业先行者之一。 依托强大的数据挖掘、统计分析和软件开发能力， 公司构建了覆盖多市场、多品种、 全频段的量化资产管理平台 。公司自主研发的低延迟交易策略和系统，经长期实践检验，形成一定技术壁垒，业绩表现获得了市场广泛认可。 蒙玺投资的投研团队有60余人，具备世界顶级高校的物理、数学、金融等多元学科背景。另外，公司在数据方面资源储备充足，除常用的量 价、基本面数据外，每年额外有千万级别另类数据购买成本，构建来自全球200+的 ...

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 今年以来， A股、港股、美股震荡上行，均录得不同程度涨幅 。截至11月底，年内上证指数、深证成指和创业板指分别上涨约16.02%、 24.67%、42.54%；港股的恒生指数和恒生科技指数涨幅均超过25%；美股方面，纳斯达克指数涨幅领先，累计上涨约21%，标普500指数涨幅为 16.45%。 在这样的市场环境下， 不少证券投资类私募凭借出色的业绩表现获投资者认可，从而实现规模显著增长 。根据中基协发布的最新私募基金管理 人登记及产品备案月报，截至2025年10月末，存续私募基金管理规模首次突破22万亿元，创下历史新高。其中，私募证券投资基金规模达7.01 万亿元，较2024年末增加1.8万亿元，增幅超过34%，成为本轮私募规模增长的"主力军"。 那么，随着私募行业迈入22万亿元的新时代，是否大多数机构都实现了规模跃升？有哪些私募管理人的规模正快速上升？他们的业绩表现如何？ 本文将为读者一一揭晓。 （需要说明的是， 根据中国基金业协会规模分类，证券投资类私募的管理规模被划分为 "0-5亿、5-10亿、10-20亿、20-50亿、50-100亿、10 ...